Non-contrast diffusion MRI holds great potential to screen women for breast cancer. Restriction spectrum imaging (RSI) is an advanced diffusion-weighted imaging (DWI) technique that reflects the high nuclear to cytoplasm ratio observed in cancer cells. This abstract explores RSI as a technique to non-invasively identify malignant from benign masses on non-contrast MRI by measuring RSI cellularity index (RSI-CI). Biopsy-proven malignant masses demonstrate high cellularity index compared to benign lesions. In this pilot study, RSI differentiates malignant from benign masses without contrast imaging, and could prove useful as a screening tool.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords